7.37 Molecular and Engineering Aspects of Biotechnology


Class Info

Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and stem cells; glycoengineering of recombinant proteins; normal and pathological signaling by growth factors and their receptors; receptor trafficking; monoclonal antibodies as therapeutics; protein pharmacology and delivery; stem cell-derived tissues as therapeutics; RNA therapeutics; combinatorial protein engineering; and new antitumor drugs.

This class has 2.005, 3.012, 5.60, 20.110, and 7.06 as prerequisites.

7.37 will be offered this semester (Spring 2019). It is instructed by H. Lodish and L. Griffith.

This class counts for a total of 12 credits.

You can find more information at the MIT Department of Biology: 7.37j/10441j - Molecular & Engineering Aspects of Biotechnology site or on the 7.37 Stellar site.

MIT 7.37 Molecular and Engineering Aspects of Biotechnology Related Textbooks
MIT 7.37 Molecular and Engineering Aspects of Biotechnology On The Web

© Copyright 2015